Related Experiment Video

Updated: May 24, 2026

Electromagnetic Source Imaging in Presurgical Evaluation of Children with Drug-Resistant Epilepsy
09:57

Electromagnetic Source Imaging in Presurgical Evaluation of Children with Drug-Resistant Epilepsy

Published on: September 20, 2024

Factors associated with behavioral problems in children with idiopathic epilepsy

Vaios Dafoulis1, Efrosini Kalyva

  • 1School of Medicine, Aristotle University of Thessaloniki, Greece. vadafoulis@yahoo.gr

Epilepsy Research
|February 22, 2012
PubMed

Insights

Children with idiopathic epilepsy exhibit more behavioral issues like hyperactivity and conduct problems compared to healthy peers. Factors such as later epilepsy onset and polytherapy correlate with these behavioral challenges.

Area of Science:

  • Pediatric Neurology
  • Child Psychology
  • Epilepsy Research

Background:

  • Idiopathic epilepsy is a common neurological disorder in children.
  • Behavioral problems are frequently observed in children with epilepsy.
  • Understanding these problems and associated factors is crucial for comprehensive care.

Purpose of the Study:

  • To compare behavioral problems in children with idiopathic epilepsy versus healthy controls.
  • To identify factors associated with behavioral problems in pediatric epilepsy.
  • To investigate differences based on epilepsy type (focal vs. generalized).

Main Methods:

  • Parent proxy-reports using Vanderbilt ADHD Diagnostic Parent Rating Scale and Strengths and Difficulties Questionnaire.
  • Clinical interviews (K-SADS-PL) with children diagnosed with idiopathic epilepsy.
  • Comparative analysis between 106 children with epilepsy and 305 healthy controls (ages 6-9).

Main Results:

  • Parents reported increased hyperactivity, emotional, and conduct problems, with less prosocial behavior in children with epilepsy.
  • No significant differences were found in peer problems, inattention, oppositional/defiant disorder, or anxiety/depression.
  • Later age of onset, polytherapy, male gender, and seizure frequency predicted behavioral problems.
  • Children with benign focal epilepsy showed fewer behavioral problems than those with generalized epilepsy.

Conclusions:

  • Children with idiopathic epilepsy experience a distinct pattern of behavioral problems compared to healthy peers.
  • Epilepsy characteristics (onset, type, treatment) and patient demographics influence behavioral outcomes.
  • Targeted interventions addressing these specific behavioral issues and associated factors are warranted.

More Related Videos

Behavioral Characterization of Pentylenetetrazole-induced Seizures: Moving Beyond the Racine Scale07:35

Behavioral Characterization of Pentylenetetrazole-induced Seizures: Moving Beyond the Racine Scale

Published on: July 8, 2025

Interictal High Frequency Oscillations Detected with Simultaneous Magnetoencephalography and Electroencephalography as Biomarker of Pediatric Epilepsy10:22

Interictal High Frequency Oscillations Detected with Simultaneous Magnetoencephalography and Electroencephalography as Biomarker of Pediatric Epilepsy

Published on: December 6, 2016

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Epilepsy ll: Types01:22

Epilepsy ll: Types

Recurrent seizures, stemming from abnormal electrical activity in the brain, are the defining characteristic of epilepsy, a chronic neurological condition. Because seizure features vary greatly, epilepsy is classified using two systems: by seizure type and by epilepsy syndromes. These classifications enable clinicians to describe seizure patterns and select suitable treatment strategies.I. Classification by Seizure Type1. Focal EpilepsyFocal epilepsy begins in one hemisphere of the brain.
Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Seizures l: Introduction01:20

Seizures l: Introduction

Understanding seizures and epilepsy relies on key definitions that help in recognizing, classifying, and managing these disorders. These definitions provide a framework for recognizing, classifying, and managing seizure disorders.DefinitionsA seizure is a sudden, abnormal burst of electrical activity in the brain that can cause changes in awareness, movement, sensation, or behavior, depending on the area involved. Epilepsy is a chronic condition characterized by recurrent, unprovoked seizures,...
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...